Divya Rishi Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.60 M
- Revenue Growth 103.60%
- Profit Growth 119.12%
- Ebitda 51.18%
- Net Worth 10.49%
- Total Assets -8.24%
About Divya Rishi Pharmacy
Divya Rishi Pharmacy Private Limited (DRPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 May 2015 (Nine years and eight months 28 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.60 M.
Namrata Pandey and Kamlesh Shukla serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999MH2015PTC264989
- Company No.
264989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Divya Rishi Pharmacy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamlesh Shukla  | Director | 28-May-2015 | Current |
| Namrata Pandey | Director | 28-May-2015 | Current |
Financial Performance of Divya Rishi Pharmacy.
Divya Rishi Pharmacy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 103.6% increase. The company also saw a substantial improvement in profitability, with a 119.12% increase in profit. The company's net worth Soared by an impressive increase of 10.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Divya Rishi Pharmacy?
Unlock access to Divya Rishi Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Human Welfare Education FoundationNamrata Pandey and Kamlesh Shukla are mutual person
- Kamal Shree Hari Har Real Estate Limited
Kamlesh Shukla is a mutual person
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2021 | Bank Of India | ₹0.60 M | Open |
How Many Employees Work at Divya Rishi Pharmacy?
Unlock and access historical data on people associated with Divya Rishi Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Divya Rishi Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Divya Rishi Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.